Syngene International gets FIPB approval
Foreign investment limit raised to 44 per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biocon
Kiran Mazumdar Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015
She is the only India-based business leader featuring on the list
Kiran Mazumdar-Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015
She is the only India based business leader featuring on the list
Biocon-Mylan programmes make clinical progress
PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete
Biocon has…
Biocon top line grows 15 per cent in Q4 FY15
Research services subsidiary Syngene delivers 27 per cent growth
Syngene seeks approval for IPO, files DRHP
Offer allows Biocon to monetise its shareholding in Syngene
ABLE elects new office bearers
To focus on improved strategies to catapult the industry to new heights
Biocon receives approval for Insulin Glargine in Mexico through its partner PiSA Farmaceutica
The combined market for Insulin Glargine in Mexico is estimated to be in excess of $40 million
Biocon recognised for outstanding contribution to public health by WHO – India
Biocon's integrated healthcare initiatives is constantly engaged in improving the quality of life of several thousand communities…
ABLE elects new office bearers
To focus on improved strategies to catapult the industry to new heights
The executive council of the Association of Biotechnology…